These tables are also available in a printable version (PDF, 222 KB).
Comprehensive ICD-10 Casefinding "Must Collect" Code List for Reportable Tumors (Effective Date: 1/1/2012)
ICD-10 Code^ | Explanation of Code |
---|---|
B21._ | Human Immunodeficiency virus [HIV] disease with malignant neoplasms |
C00._ - C97._ | Malignant neoplasms |
D00._ - D09._ | In-situ neoplasms |
D18.0, D18.1 | Hemangioma and Lymphangioma, any site |
D32._ - D33._ | Benign neoplasm of meninges (cerebral, spinal and unspecified), brain and other parts of central nervous systems |
D35.2 - D35.4 | Benign neoplasm of pituitary gland, craniopharyngeal duct, pineal gland |
D42._ - D43._ | Neoplasm of uncertain or unknown behavior of meninges, brain and central nervous system |
D44.3 - D44.5 | Neoplasm of uncertain or unknown behavior of pituitary gland, craniopharyngeal duct and pineal gland |
D45, D46._ | Polycythemia vera, Refractory Anemia |
D47.1, D47.3, D47.7, D47.9 | Other neoplasms of uncertain or unknown behavior of lymphoid, hematopoietic, and related tissue |
D48.9 | Neoplasm of uncertain or unknown behavior, unspecified |
D76._ | Certain diseases involving lymphoreticular tissue and reticulohistiocytic system |
NOTE: Cases with these codes should be screened as registry time allows. These are neoplasm-related secondary conditions for which there should also be a primary diagnosis of a reportable neoplasm. Experience in the SEER registries has shown that using the supplementary list increases casefinding for benign brain and CNS, hematopoietic, and other reportable neoplasms.
(This list is to be used to help identify cases that MAY be reportable to the cancer registry. This is not a list of reportable neoplasms or reportable terms)
Supplementary List: ICD-10 Code List to Screen for Cancer Cases Not Identified by Other Codes (Effective Date: 1/1/2012)
ICD-10 Code^ | Explanation of Code |
---|---|
B20._, B22 - B24 | Human immunodeficiency virus [HIV] disease |
B99 | Other infectious diseases (Human papillomavirus, Retrovirus-HTLV types I, II and 2) |
D10._ - D41._, D44._ | Benign neoplasms (except for D32._, D33._, D35.2-D35.4) and neoplasms of uncertain or unknown behavior(except for D44.3-D44.5) |
D47.0, D47.2 | Other neoplasms of uncertain or unknown behavior of lymphoid, hematopoietic, and related tissue |
D48._ | Neoplasms of uncertain or unknown behavior |
D60._, D61._, D63.0, D64._ | Aplastic anemias and other anemias (except for D61.0) |
D69.4 - D69.9 | Other thrombocytopenia |
D70 | Agranulocytosis |
D72.1 | Eosinophilia |
D75.8 | Other specified diseases of blood and blood forming organs |
D80.3 - D80.5 | Selective deficiency of immunoglobulin |
D81.0 - D81.2 | Severe combined immunodeficiency [SCID] ) |
D84.9 | Immunodeficiency, unspecified |
D89._ | Other disorders involving the immune mechanism, not elsewhere classified |
E13._ | Other specified diabetes mellitus |
E31.9 | Polyglandular dysfunction, unspecified |
E88.0, E88.8 | Other metabolic disorders |
G31.8 | Other specified degenerative diseases of nervous system |
G52.8 | Disorders of other specified cranial nerves |
G54.8 | Other nerve root and plexus disorders |
G62.8 | Other specified polyneuropathies |
G70.8 | Other specified myoneural disorders |
G90.8 | Other disorders of autonomic nervous system |
G91.8 | Other hydrocephalus |
G96.8 | Other specified disorders of central nervous system |
J84.8 | Other specified interstitial pulmonary diseases |
J90 | Pleural effusion, not elsewhere classified |
J93.1 | Other spontaneous pneumothorax |
M12.8 | Other specific arthropathies, not elsewhere classified |
M62.8 | Other specified disorders of muscle |
M84.4 | Pathologic fracture, not elsewhere classified |
M89.8 | Other specified disorders of bone |
O01._ | Hydatidiform mole |
O99.8 | Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium |
Q85.0 | Neurofibromatosis (nonmalignant) (9540/1) |
Q90._ | Down’s syndrome |
R18 | Ascites |
R52.9 | Pain, unspecified |
R53 | Malaise and fatigue |
R59._ | Enlarged lymph nodes |
R82.8 | Abnormal findings on cytological and histological examination of urine |
R83.6, R83.7, R84.6, R84.7, R85.6, R85.7, R86.6, R86.7, R87.6, R87.7, R89.6, R89.7 | Abnormal findings on cytological and histological examination of: cerebrospinal fluid, respiratory organs and thorax, digestive organs and abdominal cavity, male genital organs, female genital organs and other organs systems and tissues |
R91, R92 | Abnormal findings on diagnostic imaging of lung and breast |
Y42.1, Y42.6 | Adverse reaction to hormone antagonists, antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified |
Y43.1 - Y43.4 | Adverse effects in therapeutic use, antineoplastic products or drugs |
Y43.9 | Adverse effects in therapeutic use, primarily systemic agent, unspecified |
Y44.9 | Other and unspecified agents affecting blood constituents |
Y63.2 | Failure in dosage, overdose of radiation given during therapy |
Y81.2 | General and plastic surgery devices associated with adverse incidents-prosthetic and other implants, materials, and accessory devices |
Y83.0 | Surgical operation with transplant of whole organ |
Y84.2 | Abnormal reaction, radiological procedure and radiotherapy |
Y84.9 | Other medical procedures (abnormal reaction) |
The following codes are associated with the paraneoplastic syndrome. Paraneoplastic syndrome by itself is not cancer. It’s a disease or symptom that is the consequence of cancer but is not due to the local presence of cancer cells. A paraneoplastic syndrome may be the first sign of cancer. These codes have been removed from the supplemental list and are now in their own list.
ICD-10 Code^ | Explanation of Code |
---|---|
E22.2 | Syndrome of inappropriate secretion of antidiuretic hormone |
E34.0 | Carcinoid syndrome |
E34.1 | Other hypersecretion of intestinal hormones |
E34.8 | Other specified endocrine disorders |
E83.5 | Disorders of calcium metabolism |
G04.8 | Other encephalitis, myelitis, and encephalomyelitis |
H55 | Nystagmus and other irregular eye movements |
L10.8 | Other pemphigus |
L30.4 | Erythrema intertrigo |
L53.8 | Other specified erythematous conditions |
L83 | Acanthosis nigricans |
L88 | Pyoderma gangrenosum |
L98.2 | Febrile neutrophilic dermatosis [Sweet] |
M33.2 | Polymyositis |
M33.9 | Dermatopolymyositis, unspecified |
^ World Health Organization. International Statistical Classification of Diseases and Related Health problems, Tenth Revision. Geneva: World Health Organization. 2007